A multiscale investigation of the living human brain
A multiscale investigation of the living human brain
批准号:
10260466
负责人:
ALEXANDER W CHARNEY
金额:
$68.43万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-15 至 2025-05-31
关键词:
AddressAgeAlzheimer&aposs disease related dementiaAutopsyBilateralBiologyBiopsyBrainCellsCessation of lifeCohort AnalysisCommunitiesDataData AnalysesData SetDeep Brain StimulationFundingGenderGenerationsGenomeGenomicsGenotypeGoalsHumanIndividualInvestigationKnowledgeMedical HistoryModernizationMolecularMolecular BiologyMolecular ProfilingMultiomic DataNeurobiologyNeurocognitiveOutputParticipantPathogenesisPhenotypePlayPrefrontal CortexProceduresProcessProteomeProteomicsQuality ControlResolutionResourcesRoleSamplingSiteSpecimenStructureSurveysTissuesUncertaintyWorkbrain tissuecase controlcell typecohortexperimental studygenome-widehuman subjectinnovationinsightlipidomelipidomicsmetabolomemetabolomicsmolecular modelingmultimodalitymultiple omicsneuroimagingneuropsychiatrysingle-cell RNA sequencingtraittranscriptometranscriptome sequencingtranscriptomicsvirtual
中文摘要
摘要
英文摘要
ABSTRACT
Molecular investigations of Alzheimer’s disease and related dementias over the past decade have largely relied on postmortem specimens due to the inaccessibility of the brain in living people. At least two serious limitations are inherent to this framework. First, the molecular impact of death and the preceding agonal process on the human brain are unknown. This uncertainty looms over the field as a potential confounder of virtually all modern neurobiological studies of Alzheimer’s disease and related dementias in humans. Second, profiling the brain postmortem decouples molecular biology from deep neuropsychiatric assessment and neuroimaging. As a result, a holistic narrative of how molecular biology influences brain structure and functions dysregulated in Alzheimer’s disease and related dementias has failed to emerge. These serious limitations could be addressed by the ability to molecularly profile the brain in living people. Here, we address these serious limitations through the Living Brain Project, wherein we perform comprehensive multiomic molecular profiling of living and postmortem human brain tissue. The primary innovation of the LBP is a safe, scalable procedure for sampling the dorsolateral prefrontal cortex (DLPFC) in living people. We will profile the genome, transcriptome (bulk and single-cell), proteome, metabolome and lipidome in over 500 living and postmortem human subjects. Analyses of this data will identify molecular signatures differentiating the living and postmortem states. We will harness these insights to determine the extent to which they have confounded postmortem studies of Alzheimer’s disease and related dementias. Finally, we will integrate these multiomics datasets with neuroimaging and neurocognitive assessments from the same individuals. To our knowledge, the proposed experiments and analyses will comprise (1) the largest molecular study of the living human brain, (2) the largest molecular comparison of living and postmortem human brain tissues, and (3) the largest effort pairing multiomic molecular profiles of the brain with neuroimaging and deep neurocognitive phenotyping from the same living individuals. We anticipate fundamental advances in knowledge of human brain biology and the pathogenesis of Alzheimer’s disease and related dementias will be made by making this rich dataset freely available to scientific community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2/3 Sequencing and Trans-Diagnostic Phenotyping of Severe Mental Illness in Diverse Populations
-
批准号:10503976
-
项目类别:
-
资助金额:$82.18万
-
财政年份:2022
-
负责人:ALEXANDER W CHARNEY
-
依托单位:
A multiscale investigation of the living human brain
-
批准号:10668271
-
项目类别:
-
资助金额:$66.26万
-
财政年份:2020
-
负责人:ALEXANDER W CHARNEY
-
依托单位:
A multiscale investigation of the living human brain
-
批准号:10450142
-
项目类别:
-
资助金额:$67.06万
-
财政年份:2020
-
负责人:ALEXANDER W CHARNEY
-
依托单位:
A multiscale investigation of the living human brain
-
批准号:10035009
-
项目类别:
-
资助金额:$38.53万
-
财政年份:2020
-
负责人:ALEXANDER W CHARNEY
-
依托单位:
3/4: Leveraging EHR-linked biobanks for deep phenotyping, polygenic risk score modeling, and outcomes analysis in psychiatric disorders
-
批准号:10197807
-
项目类别:
-
资助金额:$42.93万
-
财政年份:2019
-
负责人:ALEXANDER W CHARNEY
-
依托单位:
3/4: Leveraging EHR-linked biobanks for deep phenotyping, polygenic risk score modeling, and outcomes analysis in psychiatric disorders
-
批准号:10414027
-
项目类别:
-
资助金额:$42.93万
-
财政年份:2019
-
负责人:ALEXANDER W CHARNEY
-
依托单位:
3/4: Leveraging EHR-linked biobanks for deep phenotyping, polygenic risk score modeling, and outcomes analysis in psychiatric disorders
-
批准号:10633130
-
项目类别:
-
资助金额:$42.93万
-
财政年份:2019
-
负责人:ALEXANDER W CHARNEY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: